Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Eli Lilly has committed to setting a new standard for on-screen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.” In the ...

Eli Lilly is calling on European countries to make “urgent improvements” to their Alzheimer’s disease diagnostic testing practices just weeks after nabbing a new approval on the continent for its ...

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Amid Eli Lilly's efforts to strengthen its global manufacturing network, the Indianapolis pharma giant is splashing more than $1 billion into its Indian operations, with plans to tap local partners ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...

Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...

It has a couple of GLP-1 products that account for more than half of its top line. Competition in this space has been on the rise, including from top pharma companies. Whether it can continue rallying ...

NACOGDOCHES COUNTY, Texas (KTRE) - The Lilly Grove Special Utility District has issued a boil water notice due to a leak caused by a fiber optic installation. To ensure the destruction of all harmful ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Lily-Rose Depp attended Matthieu Blazy’s first collection for Chanel during Paris Fashion Week. Corbis via Getty Images The industry has been abuzz about the recent shake-up amongst creative directors ...